{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:28:41Z","timestamp":1759228121442,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Indian Council of Medical Research- Center for Advanced Research in Intestinal diseases."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-022-04216-5","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T19:31:16Z","timestamp":1657827076000},"page":"1817-1826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-5971","authenticated-orcid":false,"given":"Mukesh Kumar","family":"Ranjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-3237","authenticated-orcid":false,"given":"Sudheer Kumar","family":"Vuyyuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5363-7273","authenticated-orcid":false,"given":"Bhaskar","family":"Kante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5630-8715","authenticated-orcid":false,"given":"Peeyush","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0953-7168","authenticated-orcid":false,"given":"Sandeep K.","family":"Mundhra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9196-1437","authenticated-orcid":false,"given":"Rithvik","family":"Golla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-263X","authenticated-orcid":false,"given":"Raju","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6910-062X","authenticated-orcid":false,"given":"Peush","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-8573","authenticated-orcid":false,"given":"Prasenjit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-2194","authenticated-orcid":false,"given":"Govind","family":"Makharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-0144","authenticated-orcid":false,"given":"Saurabh","family":"Kedia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1577-0118","authenticated-orcid":false,"given":"Vineet","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"issue":"1","key":"4216_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan GG, Windsor JW (2021) The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 18(1):56\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00360-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4216_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","volume":"5","author":"S Alatab","year":"2020","unstructured":"Alatab S, Sepanlou SG, Ikuta K et al (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5(1):17\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(19)30333-4","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"4216_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000465522","volume":"2","author":"S Kedia","year":"2017","unstructured":"Kedia S, Ahuja V (2017) Epidemiology of inflammatory bowel disease in India: the great shift east. Inflamm Intest Dis 2(2):102\u2013115. https:\/\/doi.org\/10.1159\/000465522","journal-title":"Inflamm Intest Dis"},{"issue":"1","key":"4216_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomoll\u00f3n","year":"2017","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis 11(1):3\u201325. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw168","journal-title":"J Crohns Colitis"},{"key":"4216_CR5","doi-asserted-by":"publisher","unstructured":"Magro F, Gionchetti P, Eliakim R et al (2017) Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and Ileo-anal pouch disorders. Journal of Crohn\u2019s Colitis. 11(6). https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx008","DOI":"10.1093\/ecco-jcc\/jjx008"},{"issue":"5945","key":"4216_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/bmj.4.5945.627","volume":"4","author":"DP Jewell","year":"1974","unstructured":"Jewell DP, Truelove SC (1974) Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J 4(5945):627\u2013630. https:\/\/doi.org\/10.1136\/bmj.4.5945.627","journal-title":"Br Med J"},{"issue":"1","key":"4216_CR7","first-page":"14","volume":"19","author":"A Sood","year":"2000","unstructured":"Sood A, Midha V, Sood N, Kaushal V (2000) Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial. Indian J Gastroenterol 19(1):14\u201316","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"4216_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-2036.2009.04023.x","volume":"30","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, Linares PM, Mcnicholl AG, Mat\u00e9 J, Gomoll\u00f3n F (2009) Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis. Aliment Pharmacol Ther 30(2):126\u2013137. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04023.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4216_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/gutjnl-2019-320185","volume":"70","author":"E Stournaras","year":"2021","unstructured":"Stournaras E, Qian W, Pappas A et al (2021) Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn\u2019s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource. Gut 70(4):677\u2013686. https:\/\/doi.org\/10.1136\/gutjnl-2019-320185","journal-title":"Gut"},{"key":"4216_CR10","doi-asserted-by":"publisher","unstructured":"Raine T, Bonovas S, Burisch J et al (2021) ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohn\u2019s Colitis. Published Online Oct 12\u00a02021:jjab178. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab178","DOI":"10.1093\/ecco-jcc\/jjab178"},{"key":"4216_CR11","doi-asserted-by":"publisher","unstructured":"Torres J, Organisation [ECCO on behalf of the EC and C, Bonovas S et al (2020) ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment. J Crohns Colitis 14(1):4\u201322. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz180","DOI":"10.1093\/ecco-jcc\/jjz180"},{"issue":"18","key":"4216_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","volume":"376","author":"WJ Sandborn","year":"2017","unstructured":"Sandborn WJ, Su C, Sands BE et al (2017) Tofacitinib as induction and maintenance therapy for ulcerative colitis. N Engl J Med 376(18):1723\u20131736. https:\/\/doi.org\/10.1056\/NEJMoa1606910","journal-title":"N Engl J Med"},{"key":"4216_CR13","unstructured":"1 Recommendations | Tofacitinib for moderately to severely active ulcerative colitis | Guidance | NICE. Accessed June 27, 2022. https:\/\/www.nice.org.uk\/guidance\/ta547\/chapter\/1-Recommendations"},{"issue":"3","key":"4216_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jgh.14533","volume":"34","author":"SZ Huang","year":"2019","unstructured":"Huang SZ, Liu ZC, Liao WX et al (2019) Risk of skin cancers in thiopurines-treated and thiopurines-untreated patients with inflammatory bowel disease: a systematic review and meta-analysis. J Gastroenterol Hepatol 34(3):507\u2013516. https:\/\/doi.org\/10.1111\/jgh.14533","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"4216_CR15","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/ibd.21582","volume":"17","author":"ACW Vos","year":"2011","unstructured":"Vos ACW, Bakkal N, Minnee RC et al (2011) Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflamm Bowel Dis 17(9):1837\u20131845. https:\/\/doi.org\/10.1002\/ibd.21582","journal-title":"Inflamm Bowel Dis"},{"issue":"8097","key":"4216_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/s0140-6736(78)92524-2","volume":"2","author":"DP O\u2019Donoghue","year":"1978","unstructured":"O\u2019Donoghue DP, Dawson AM, Powell-Tuck J, Bown RL, Lennard-Jones JE (1978) Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn\u2019s disease. Lancet 2(8097):955\u2013957. https:\/\/doi.org\/10.1016\/s0140-6736(78)92524-2","journal-title":"Lancet"},{"issue":"11","key":"4216_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/j.1365-2036.2004.01944.x","volume":"19","author":"M Vilien","year":"2004","unstructured":"Vilien M, Dahlerup JF, Munck LK, N\u00f8rregaard P, Gr\u00f8nbaek K, Fallingborg J (2004) Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn\u2019s disease: increased relapse rate the following year. Aliment Pharmacol Ther 19(11):1147\u20131152. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.01944.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"6844","key":"4216_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/bmj.305.6844.20","volume":"305","author":"AB Hawthorne","year":"1992","unstructured":"Hawthorne AB, Logan RF, Hawkey CJ et al (1992) Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 305(6844):20\u201322. https:\/\/doi.org\/10.1136\/bmj.305.6844.20","journal-title":"BMJ"},{"issue":"7","key":"4216_CR19","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1053\/j.gastro.2005.03.031","volume":"128","author":"M L\u00e9mann","year":"2005","unstructured":"L\u00e9mann M, Mary JY, Colombel JF et al (2005) A randomized, double-blind, controlled withdrawal trial in Crohn\u2019s disease patients in long-term remission on azathioprine. Gastroenterology 128(7):1812\u20131818. https:\/\/doi.org\/10.1053\/j.gastro.2005.03.031","journal-title":"Gastroenterology"},{"issue":"5","key":"4216_CR20","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s10620-014-3419-5","volume":"60","author":"HH Wenzl","year":"2015","unstructured":"Wenzl HH, Primas C, Novacek G et al (2015) Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn\u2019s disease. Dig Dis Sci 60(5):1414\u20131423. https:\/\/doi.org\/10.1007\/s10620-014-3419-5","journal-title":"Dig Dis Sci"},{"issue":"11\u201312","key":"4216_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/apt.12980","volume":"40","author":"NA Kennedy","year":"2014","unstructured":"Kennedy NA, Kalla R, Warner B et al (2014) Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Aliment Pharmacol Ther 40(11\u201312):1313\u20131323. https:\/\/doi.org\/10.1111\/apt.12980","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"4216_CR22","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.cgh.2021.06.014","volume":"19","author":"A Cassinotti","year":"2021","unstructured":"Cassinotti A, Corona A, Duca P et al (2021) Noninvasive monitoring after azathioprine withdrawal in patients with inflammatory bowel disease in deep remission. Clin Gastroenterol Hepatol 19(11):2293-2301.e1. https:\/\/doi.org\/10.1016\/j.cgh.2021.06.014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"4216_CR23","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/ajg.2009.410","volume":"104","author":"A Cassinotti","year":"2009","unstructured":"Cassinotti A, Actis GC, Duca P et al (2009) Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal. Am J Gastroenterol 104(11):2760\u20132767. https:\/\/doi.org\/10.1038\/ajg.2009.410","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"4216_CR24","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1053\/j.gastro.2015.08.055","volume":"149","author":"J Torres","year":"2015","unstructured":"Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J (2015) Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease. Gastroenterology 149(7):1716\u20131730. https:\/\/doi.org\/10.1053\/j.gastro.2015.08.055","journal-title":"Gastroenterology"},{"key":"4216_CR25","doi-asserted-by":"publisher","unstructured":"Prefontaine E, MacDonald JK, Sutherland LR (2010) Azathioprine or 6\u2010mercaptopurine for induction of remission in Crohn\u2019s disease. Cochrane Data Syst Rev (6). https:\/\/doi.org\/10.1002\/14651858.CD000545.pub3","DOI":"10.1002\/14651858.CD000545.pub3"},{"key":"4216_CR26","doi-asserted-by":"publisher","unstructured":"Su C, Lichtenstein GR (2004) Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine. Gastroenterol Clin North Am 33(2):209\u2013234, viii. https:\/\/doi.org\/10.1016\/j.gtc.2004.02.004","DOI":"10.1016\/j.gtc.2004.02.004"},{"issue":"7","key":"4216_CR27","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1136\/gutjnl-2020-322646","volume":"70","author":"B Verstockt","year":"2021","unstructured":"Verstockt B, Boets L, Sabino J, Vermeire S, Ferrante M (2021) Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn\u2019s disease. Gut 70(7):1416\u20131418. https:\/\/doi.org\/10.1136\/gutjnl-2020-322646","journal-title":"Gut"},{"key":"4216_CR28","doi-asserted-by":"publisher","unstructured":"Harbord M, Eliakim R, Bettenworth D et al (2017) Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis 11(7):769\u2013784. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx009","DOI":"10.1093\/ecco-jcc\/jjx009"},{"issue":"8","key":"4216_CR29","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/ibd.20884","volume":"15","author":"F van der Heide","year":"2009","unstructured":"van der Heide F, Dijkstra A, Weersma RK et al (2009) Effects of active and passive smoking on disease course of Crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis 15(8):1199\u20131207. https:\/\/doi.org\/10.1002\/ibd.20884","journal-title":"Inflamm Bowel Dis"},{"issue":"8996","key":"4216_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0140-6736(96)90402-x","volume":"347","author":"Y Bouhnik","year":"1996","unstructured":"Bouhnik Y, L\u00e9mann M, Mary JY et al (1996) Long-term follow-up of patients with Crohn\u2019s disease treated with azathioprine or 6-mercaptopurine. Lancet 347(8996):215\u2013219. https:\/\/doi.org\/10.1016\/s0140-6736(96)90402-x","journal-title":"Lancet"},{"issue":"4","key":"4216_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gut.50.4.485","volume":"50","author":"AG Fraser","year":"2002","unstructured":"Fraser AG, Orchard TR, Jewell DP (2002) The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 50(4):485\u2013489. https:\/\/doi.org\/10.1136\/gut.50.4.485","journal-title":"Gut"},{"issue":"34","key":"4216_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011814","volume":"97","author":"X Qian","year":"2018","unstructured":"Qian X, Wang T, Shen J, Ran Z (2018) Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: a prospective observational study. Medicine 97(34):e11814. https:\/\/doi.org\/10.1097\/MD.0000000000011814","journal-title":"Medicine"},{"issue":"8","key":"4216_CR33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s00535-003-1139-2","volume":"38","author":"T Hibi","year":"2003","unstructured":"Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T (2003) Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol 38(8):740\u2013746. https:\/\/doi.org\/10.1007\/s00535-003-1139-2","journal-title":"J Gastroenterol"},{"issue":"4","key":"4216_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1756283X16643509","volume":"9","author":"HY Shi","year":"2016","unstructured":"Shi HY, Chan FKL, Leung WK et al (2016) Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registry. Therap Adv Gastroenterol 9(4):449\u2013456. https:\/\/doi.org\/10.1177\/1756283X16643509","journal-title":"Therap Adv Gastroenterol"},{"issue":"6","key":"4216_CR35","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/gut.2004.056358","volume":"54","author":"PDR Higgins","year":"2005","unstructured":"Higgins PDR, Schwartz M, Mapili J, Krokos I, Leung J, Zimmermann EM (2005) Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut 54(6):782\u2013788. https:\/\/doi.org\/10.1136\/gut.2004.056358","journal-title":"Gut"},{"issue":"2","key":"4216_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/00365520310000654","volume":"38","author":"SL Jowett","year":"2003","unstructured":"Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR (2003) Defining relapse of ulcerative colitis using a symptom-based activity index. Scand J Gastroenterol 38(2):164\u2013171. https:\/\/doi.org\/10.1080\/00365520310000654","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"4216_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ecco-jcc\/jjx101","volume":"12","author":"G Doherty","year":"2018","unstructured":"Doherty G, Katsanos KH, Burisch J et al (2018) European Crohn\u2019s and Colitis Organisation topical review on treatment withdrawal [\u2018Exit Strategies\u2019] in inflammatory bowel disease. Journal of Crohn\u2019s and Colitis 12(1):17\u201331. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx101","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"1","key":"4216_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","volume":"145","author":"SC Ng","year":"2013","unstructured":"Ng SC, Tang W, Ching JY et al (2013) Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn\u2019s and colitis epidemiology study. Gastroenterology 145(1):158-165.e2. https:\/\/doi.org\/10.1053\/j.gastro.2013.04.007","journal-title":"Gastroenterology"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04216-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-022-04216-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04216-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T07:05:45Z","timestamp":1660806345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-022-04216-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["4216"],"URL":"https:\/\/doi.org\/10.1007\/s00384-022-04216-5","relation":{},"ISSN":["1432-1262"],"issn-type":[{"type":"electronic","value":"1432-1262"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"8 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}